These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 870000)

  • 41. Effect of hydroxyethyl starch on the structure of thrombin- and reptilase-induced fibrin gels.
    Carr ME
    J Lab Clin Med; 1986 Dec; 108(6):556-61. PubMed ID: 2431085
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The activation of plasma factor XIII with the snake venom enzymes ancrod and batroxobin marajoensis.
    Walter M; Nyman D; Krajnc V; Duckert F
    Thromb Haemost; 1977 Aug; 38(2):438-46. PubMed ID: 579487
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fibrin and cancer.
    Costantini V; Zacharski LR
    Thromb Haemost; 1993 May; 69(5):406-14. PubMed ID: 8322261
    [No Abstract]   [Full Text] [Related]  

  • 44. Influence of Ca2+ on the structure of reptilase-derived and thrombin-derived fibrin gels.
    Carr ME; Gabriel DA; McDonagh J
    Biochem J; 1986 Nov; 239(3):513-6. PubMed ID: 3548699
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dysfibrinogenemia and lupus anticoagulant in a patient with recurrent thrombosis.
    Al-Mondhiry H; Galanakis D
    J Lab Clin Med; 1987 Dec; 110(6):726-33. PubMed ID: 3119749
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The cleavage and inactivation of plasminogen activator inhibitor type 1 and alpha2-antiplasmin by reptilase, a thrombin-like venom enzyme.
    Urano T; Ihara H; Takada Y; Fujie M; Takada A
    Blood Coagul Fibrinolysis; 2000 Mar; 11(2):145-53. PubMed ID: 10759007
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Abnormalities of fibrin formation in benign viral hepatitis (author's transl)].
    Thabaut A; Laverdant C; Durosoir JL; Cristau P; Essioux J; Molinié C
    Ann Med Interne (Paris); 1979; 130(1):35-8. PubMed ID: 434713
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impaired fibrin formation in advanced cirrhosis.
    Dettori AG; Ponari O; Civardi E; Megha A; Pini M; Poti R
    Haemostasis; 1977; 6(2):137-48. PubMed ID: 863294
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Hypodysfibrinogenemia: fibrinogen giessen II (author's transl)].
    Krause WH; Huth K; Heene DL; Lasch HG
    Klin Wochenschr; 1975 Aug; 53(16):781-2. PubMed ID: 1165625
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fibrinopeptide A release is necessary for effective B:b interactions in polymerisation of variant fibrinogens with impaired A:a interactions.
    Soya K; Terasawa F; Okumura N
    Thromb Haemost; 2013 Feb; 109(2):221-8. PubMed ID: 23238100
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nature and biological activities of degradation products of fibrinogen and fibrin.
    Kwaan HC; Barlow GH
    Annu Rev Med; 1973; 24():335-44. PubMed ID: 4575863
    [No Abstract]   [Full Text] [Related]  

  • 52. Intravascular coagulation in acute hepatic necrosis.
    Rake MO; Flute PT; Pannell G; Williams R
    Lancet; 1970 Mar; 1(7646):533-7. PubMed ID: 4190350
    [No Abstract]   [Full Text] [Related]  

  • 53. A new type of congenital dysfibrinogenaemia with defective fibrin lysis--Dusard syndrome: possible relation to thrombosis.
    Soria J; Soria C; Caen P
    Br J Haematol; 1983 Apr; 53(4):575-86. PubMed ID: 6830701
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibition of fibrin polymerization by fragment d is affected by calcium, Gly-Pro-Arg and Gly-His-Arg.
    Furlan M; Rupp C; Beck EA
    Biochim Biophys Acta; 1983 Jan; 742(1):25-32. PubMed ID: 6824684
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Thrombin-induced fibrinopeptide B release from normal and variant fibrinogens: influence of inhibitors of fibrin polymerization.
    Ruf W; Bender A; Lane DA; Preissner KT; Selmayr E; Müller-Berghaus G
    Biochim Biophys Acta; 1988 May; 965(2-3):169-75. PubMed ID: 3365451
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Potential misdiagnosis of dysfibrinogenaemia: Data from multicentre studies amongst UK NEQAS and PRO-RBDD project laboratories.
    Jennings I; Kitchen S; Menegatti M; Palla R; Walker I; Peyvandi F; Makris M
    Int J Lab Hematol; 2017 Dec; 39(6):653-662. PubMed ID: 28766854
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Circulating thrombin time anticoagulant in a procainamide-induced syndrome.
    Galanakis DK; Newman J; Summers D
    JAMA; 1978 May; 239(18):1873-4. PubMed ID: 642115
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bleeding and coagulation abnormalities in alcoholic cirrhotic liver disease.
    Ragni MV; Lewis JH; Spero JA; Hasiba U
    Alcohol Clin Exp Res; 1982; 6(2):267-74. PubMed ID: 7048981
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Acquired Dysfibrinogenemia Caused by Autoantibody Inhibiting Fibrin Polymerization in a Patient with MELAS Syndrome and Bleeding Tendency.
    Lee N; Kim JE; Yoo HJ; Gu J; Kim H; Chung J; Koh Y; Kim HK
    Ann Clin Lab Sci; 2016 Dec; 46(6):696-700. PubMed ID: 27993886
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Association of inherited dysfibrinogenaemia and protein C deficiency in two unrelated families.
    Gandrille S; Priollet P; Capron L; Roncato M; Fiessinger JN; Aiach M
    Br J Haematol; 1988 Mar; 68(3):329-37. PubMed ID: 3355791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.